NOXXON Pharma N.V.: NOXXON Announces Participation in 7th Annual Immuno-oncology Innovation Forum, May 18-20, 2021
NOXXON Pharma N.V.: NOXXON Announces Participation in 7th Annual Immuno-oncology Innovation Forum, May 18-20, 2021 NOXXON Pharma N.V. (Paris:ALNOX) (Euronext Growth Paris: ALNOX), a biotechnology company focused on improving cancer treatments by targeting the tumor microenvironment (TME), announced that it will participate in the 7 th Annual Immuno-Oncology Innovation Forum organized by Sachs Associates taking place from May 18 to May 20, 2021. Aram Mangasarian, CEO of NOXXON, will present the latest developments in NOXXON's lead compound NOX-A12 in glioblastoma and pancreatic cancer to inves...
Source: finanznachrichten.de